A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis

被引:75
作者
Blackburn, J. S. [1 ]
Liu, I. [2 ]
Coon, C. I. [1 ]
Brinckerhoff, C. E. [1 ,2 ]
机构
[1] Dartmouth Med Sch, Dept Biochem, Lebanon, NH 03756 USA
[2] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Dept Med, Lebanon, NH 03766 USA
关键词
MMP-1; PAR-1; angiogenesis; superarray; xenograft; THROMBIN RECEPTOR; CELLS; EXPRESSION; PAR-1; GROWTH; PROGRESSION; INHIBITION; MECHANISMS; PROGNOSIS; SYSTEM;
D O I
10.1038/onc.2009.272
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hallmarks of malignant melanoma are its propensity to metastasize and its resistance to treatment, giving patients with advanced disease a poor prognosis. The transition of melanoma from non-invasive radial growth phase (RGP) to invasive and metastatically competent vertical growth phase (VGP) is a major step in tumor progression, yet the mechanisms governing this transformation are unknown. Matrix metalloproteinase-1 (MMP-1) is highly expressed by VGP melanomas, and is thought to contribute to melanoma progression by degrading type I collagen within the skin to facilitate melanoma invasion. Protease activated receptor-1 (PAR-1) is activated by MMP-1, and is also expressed by VGP melanomas. However, the effects of MMP-1 signaling through PAR-1 have not been examined in melanoma. Here, we demonstrate that an MMP-1/PAR-1 signaling axis exists in VGP melanoma, and is necessary for melanoma invasion. Introduction of MMP-1 into RGP melanoma cells induced gene expression associated with tumor progression and promoted invasion in vitro, and enhanced tumor growth and conferred metastatic capability in vivo. This study demonstrates that both the type I collagenase and PAR-1 activating functions of MMP-1 are required for melanoma progression, and suggests that MMP-1 may be a major contributor to the transformation of melanoma from non-invasive to malignant disease. Oncogene (2009) 28, 4237-4248; doi: 10.1038/onc.2009.272; published online 7 September 2009
引用
收藏
页码:4237 / 4248
页数:12
相关论文
共 41 条
[1]   Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer [J].
Agarwal, Anika ;
Covic, Lidija ;
Sevigny, Leila M. ;
Kaneider, Nicole C. ;
Lazarides, Katherine ;
Azabdaftari, Gissou ;
Sharifi, Sheida ;
Kuliopulos, Athan .
MOLECULAR CANCER THERAPEUTICS, 2008, 7 (09) :2746-2757
[2]   Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas [J].
Airola, K ;
Karonen, T ;
Vaalamo, M ;
Lehti, K ;
Lohi, J ;
Kariniemi, AL ;
Keski-Oja, J ;
Saarialho-Kere, UK .
BRITISH JOURNAL OF CANCER, 1999, 80 (5-6) :733-743
[3]   Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer [J].
Arora, Puneeta ;
Ricks, Tiffany K. ;
Trejo, JoAnn .
JOURNAL OF CELL SCIENCE, 2007, 120 (06) :921-928
[4]   An evidence-based staging system for cutaneous melanoma [J].
Balch, CM ;
Soong, SJ ;
Atkins, MB ;
Buzaid, AC ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
CA-A CANCER JOURNAL FOR CLINICIANS, 2004, 54 (03) :131-149
[5]   Melanoma Epidemiology and Public Health [J].
Berwick, Marianne ;
Erdei, Esther ;
Hay, Jennifer .
DERMATOLOGIC CLINICS, 2009, 27 (02) :205-+
[6]   RNA interference inhibition of matrix metal loprotei nase-1 prevents melanoma metastasis by reducing tumor collagenase activity and angiogenesis [J].
Blackburn, Jessica S. ;
Rhodes, C. Harker ;
Coon, Charles I. ;
Brinckerhoff, Constance E. .
CANCER RESEARCH, 2007, 67 (22) :10849-10858
[7]   Matrix Metalloproteinase-1 and Thrombin Differentially Activate Gene Expression in Endothelial Cells via PAR-1 and Promote Angiogenesis [J].
Blackburn, Jessica S. ;
Brinckerhoff, Constance E. .
AMERICAN JOURNAL OF PATHOLOGY, 2008, 173 (06) :1736-1746
[8]   PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells [J].
Boire, A ;
Covic, L ;
Agarwal, A ;
Jacques, S ;
Sherifl, S ;
Kuliopulos, A .
CELL, 2005, 120 (03) :303-313
[10]  
Clark W H Jr, 1975, Semin Oncol, V2, P83